|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2008-10-14
|
|
pubmed:abstractText |
Recently, p-[(123)I]iodo-L-phenylalanine (IPA) was clinically validated for brain tumour imaging. Preclinical studies demonstrated uptake of IPA into pancreatic adenocarcinoma suggesting its diagnostic application in patients with pancreatic tumours. The aim was to study the tumour uptake of IPA in patients with pancreatic adenocarcinoma and to analyse its biodistribution and dosimetry to assess the radiation dose resulting from its diagnostic use.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0029-5566
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
47
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
220-4
|
|
pubmed:meshHeading |
pubmed-meshheading:18852930-Adenocarcinoma,
pubmed-meshheading:18852930-Aged,
pubmed-meshheading:18852930-Aged, 80 and over,
pubmed-meshheading:18852930-Female,
pubmed-meshheading:18852930-Half-Life,
pubmed-meshheading:18852930-Humans,
pubmed-meshheading:18852930-Iodine Radioisotopes,
pubmed-meshheading:18852930-Kinetics,
pubmed-meshheading:18852930-Male,
pubmed-meshheading:18852930-Metabolic Clearance Rate,
pubmed-meshheading:18852930-Middle Aged,
pubmed-meshheading:18852930-Pancreatic Neoplasms,
pubmed-meshheading:18852930-Phenylalanine,
pubmed-meshheading:18852930-Tissue Distribution,
pubmed-meshheading:18852930-Tomography, Emission-Computed, Single-Photon,
pubmed-meshheading:18852930-Whole-Body Irradiation
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Para-[(123)I]iodo-L-phenylalanine in patients with pancreatic adenocarcinoma: tumour uptake, whole-body kinetics, dosimetry.
|
|
pubmed:affiliation |
Department of Nuclear Medicine, Saarland University Medical Center, Homburg, Germany. Dirk.Hellwig@uks.eu
|
|
pubmed:publicationType |
Journal Article
|
